12 Best Performing Stocks in the Last 6 Months

Page 10 of 11

2. ABIVAX Société Anonyme (NASDAQ:ABVX)

6-Month Performance: 1,083.05%

Number of Hedge Fund Holders: 20

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best-performing stocks in the last 6 months. On July 29, Piper Sandler increased its price target for ABIVAX Société Anonyme (NASDAQ:ABVX) from $70 to $112 while keeping an “Overweight” rating.

This decision came after the research firm’s analysis of ABIVAX’s Société Anonyme (NASDAQ:ABVX) Phase 3 induction data for Obefazimod in Ulcerative Colitis (UC). Piper Sandler incorporated into its financial models the revenue potential in early-line UC treatment. This effectively doubled the firm’s revenue forecast in UC for the US market to EUR 2.656 billion by 2035.

Additionally, Piper Sandler identified a number of upcoming catalysts for ABIVAX’s Société Anonyme (NASDAQ:ABVX). These include the possibility of full presentation of UC induction data at a medical meeting in October, the release of Phase 3 UC maintenance data expected in the second quarter of 2026, and Phase 2b data for Crohn’s disease expected in the second half of 2026.

ABIVAX Société Anonyme (NASDAQ:ABVX) is a French clinical-stage biotechnology company focused on developing therapeutics for chronic inflammatory diseases.

Page 10 of 11